Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' JENSEN PB' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 67 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Elliott, TE; Elliott, BA; Regal, RR; Renier, CM; Crouse, BJ; Gangeness, DE; Witrak, MT; Jensen, PB
      Lake Superior Rural Cancer Care Project part I: An intervention trial

      CANCER PRACTICE
    2. Elliott, TE; Elliott, BA; Regal, RR; Renier, CM; Crouse, BJ; Gangeness, DE; Witrak, MT; Jensen, PB
      Lake Superior Rural Cancer Care Project part II: Provider knowledge

      CANCER PRACTICE
    3. Langer, SW; Sehested, M; Jensen, PB
      Dexrazoxane is a potent and specific inhibitor of anthracycline induced subcutaneous lesions in mice

      ANNALS OF ONCOLOGY
    4. Bergman, AM; Munch-Petersen, B; Jensen, PB; Sehested, M; Veerman, G; Voorn, DA; Smid, K; Pinedo, HM; Peters, GJ
      Collateral sensitivity to gemcitabine (2 ',2 ' -difluorodeoxycytidine) andcytosine arabinoside of daunorubicin- and VM-26-resistant variants of human small cell lung cancer cell lines

      BIOCHEMICAL PHARMACOLOGY
    5. Langer, SW; Sehested, M; Jensen, PB
      Treatment of anthracycline extravasation with dexrazoxane

      CLINICAL CANCER RESEARCH
    6. Hofland, K; Petersen, BO; Falck, J; Helin, K; Jensen, PB; Sehested, M
      Differential cytotoxic pathways of topoisomerase I and II anticancer agents after overexpression of the E2F-1/DP-1 transcription factor complex

      CLINICAL CANCER RESEARCH
    7. Sorensen, M; Jensen, PB; Herrstedt, J; Hirsch, FR; Hansen, HH
      A dose escalating study of topotecan preceding cisplatin in previously untreated patients with small-cell lung cancer

      ANNALS OF ONCOLOGY
    8. Langer, SW; Sehested, M; Jensen, PB; Buter, J; Giaccone, G
      Dexrazoxane in anthracycline extravasation

      JOURNAL OF CLINICAL ONCOLOGY
    9. Hansen, TB; Gram, J; Jensen, PB; Kristiansen, JH; Ekelund, B; Christiansen, JS; Pedersen, FB
      Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study

      CLINICAL NEPHROLOGY
    10. Jensen, PB; Ekelund, B; Nielsen, FT; Baumbach, L; Pedersen, FB; Oxhoj, H
      Changes in cardiac muscle mass and function in hemodialysis patients during growth hormone treatment

      CLINICAL NEPHROLOGY
    11. Kirchhoff, R; Jensen, PB; Nielsen, NS; Boeckstyns, MEH
      Repeated digital nerve block for pain control after tenolysis

      SCANDINAVIAN JOURNAL OF PLASTIC AND RECONSTRUCTIVE SURGERY AND HAND SURGERY
    12. Holst-Hansen, C; Stephens, RW; Johannessen, BE; Jensen, PB; Brunner, N
      Plasma Escherichia coli beta-galactosidase as a marker of tumor burden andresponse to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cells

      LABORATORY INVESTIGATION
    13. O'Doherty, RM; Jensen, PB; Anderson, P; Jones, JG; Berman, HK; Kearney, D; Newgard, CB
      Activation of direct and indirect pathways of glycogen synthesis by hepatic overexpression of protein targeting to glycogen

      JOURNAL OF CLINICAL INVESTIGATION
    14. Gasa, R; Jensen, PB; Berman, HK; Brady, MJ; DePaoli-Roach, AA; Newgard, CB
      Distinctive regulatory and metabolic properties of glycogen-targeting subunits of protein phosphatase-1 (PTG, G(L), G(M)/R-G1) expressed in hepatocytes

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Jensen, LH; Nitiss, KC; Rose, A; Dong, JW; Zhou, JF; Hu, T; Osheroff, N; Jensen, PB; Sehested, M; Nitiss, JL
      A novel mechanism of cell killing by anti-topoisomerase II bisdioxopiperazines

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Jensen, LH; Wessel, I; Moller, M; Nitiss, JL; Sehested, I; Jensen, PB
      N-terminal and core-domain random mutations in human topoisomerase II alpha conferring bisdioxopiperazine resistance

      FEBS LETTERS
    17. Sehested, M; Jensen, PB
      Small cell and its stroma: determinant of pan-resistance?

      DRUG RESISTANCE UPDATES
    18. Langer, SW; Schmidt, G; Sorensen, M; Sehested, M; Jensen, PB
      Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity

      CLINICAL CANCER RESEARCH
    19. Theilade, MD; Gram, GJ; Jensen, PB; Cianfriglia, M; Rorth, M; Hansen, JES
      Multidrug resistance and retroviral transduction potential in human small cell lung cancer cell lines

      APMIS
    20. Jensen, PB; Sehested, M; Langer, SW; Hansen, HH
      Twenty-five years of chemotherapy in small cell lung cancer sends us back to the laboratory

      CANCER TREATMENT REVIEWS
    21. Jensen, PB; Hansen, TB; Frystyk, J; Ladefoged, SD; Pedersen, FB; Christiansen, JS
      Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone

      CLINICAL NEPHROLOGY
    22. Meersma, GJ; Bakker, M; Groen, HJM; Van der Zee, AGJ; Jensen, PB; Giaccone, G; De Vries, EGE; Smit, EF
      A PCR-aided transcript titration assay (PATTY) to measure topoisomerase I gene expression in human tumor specimens

      ANTICANCER RESEARCH
    23. Sorensen, M; Sehested, M; Jensen, PB
      Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation of cleavable-complex formation by etoposide but not by amsacrine

      MOLECULAR PHARMACOLOGY
    24. Falck, J; Jensen, PB; Sehested, M
      Evidence for repressional role of an inverted CCAAT box in cell cycle-dependent transcription of the human DNA topoisomerase II alpha gene

      JOURNAL OF BIOLOGICAL CHEMISTRY
    25. Jensen, PB; Kristensen, P; Clausen, JT; Judge, ME; Hastrup, S; Thim, L; Wulff, BS; Foged, C; Jensen, J; Holst, JJ; Madsen, OD
      The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans

      FEBS LETTERS
    26. Wessel, I; Jensen, LH; Jensen, PB; Falck, J; Rose, A; Roerth, M; Nitiss, JL; Sehested, M
      Human small cell lung cancer NYH cells selected for resistance to the bisdioxopiperazine topoisomerase II catalytic inhibitor ICRF-187 demonstrate a functional R162Q mutation in the Walker A consensus ATP binding domain of the alpha isoform

      CANCER RESEARCH
    27. HOLM B; SEHESTED M; JENSEN PB
      IMPROVED TARGETING OF BRAIN-TUMORS USING DEXRAZOXANE RESCUE OF TOPOISOMERASE-II COMBINED WITH SUPRALETHAL DOSES OF ETOPOSIDE AND TENIPOSIDE

      Clinical cancer research
    28. OLESEN F; JENSEN PB; GRINSTED P; HENRIKSEN JS
      GENERAL-PRACTITIONERS AS ADVISERS AND COORDINATORS IN HOSPITALS

      Quality in health care
    29. GRAM J; HANSEN TB; JENSEN PB; CHRISTENSEN JH; LADEFOGED S; PEDERSEN FB
      THE EFFECT OF RECOMBINANT HUMAN GROWTH-HORMONE TREATMENT ON BONE AND MINERAL METABOLISM IN HEMODIALYSIS-PATIENTS

      Nephrology, dialysis, transplantation
    30. PETERS GJ; BERGMAN AM; JENSEN PB; SEHESTED M; MUNCHPETERSEN B; VEERMAN G; VOORN DA; PINEDO HM
      COLLATERAL SENSITIVITY OF GEMCITABINE OF HUMAN MULTIDRUG-RESISTANT CANCER-CELLS

      Annals of oncology
    31. KVAMME OJ; ELIASSON G; JENSEN PB
      COOPERATION OF CARE AND LEARNING ACROSS THE INTERFACE BETWEEN PRIMARYAND SECONDARY CARE - EXPERIENCES FROM 2 WORKSHOPS AT THE 15TH WONCA-WORLD-CONFERENCE-1998

      Scandinavian journal of primary health care
    32. KRISTENSEN P; JUDGE ME; THIM L; RIBEL U; CHRISTJANSEN KN; WULFF BS; CLAUSEN JT; JENSEN PB; MADSEN OD; VRANG N; LARSEN PJ; HASTRUP S
      HYPOTHALAMIC CART IS A NEW ANORECTIC PEPTIDE REGULATED BY LEPTIN

      Nature
    33. JENSEN PB; BLUME N; MIKKELSEN JD; LARSEN PJ; JENSEN HI; HOLST JJ; MADSEN OD
      TRANSPLANTABLE RAT GLUCAGONOMAS CAUSE ACUTE ONSET OF SEVERE ANOREXIA AND ADIPSIA DESPITE HIGHLY ELEVATED NPY MESSENGER-RNA LEVELS IN THE HYPOTHALAMIC ARCUATE NUCLEUS

      The Journal of clinical investigation
    34. Grue, P; Grasser, A; Sehested, M; Jensen, PB; Uhse, A; Straub, T; Ness, W; Boege, F
      Essential mitotic functions of DNA topoisomerase II alpha are not adopted by topoisomerase II beta in human h69 cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    35. JENSEN CH; HANSEN M; BRANDT J; RASMUSSEN HB; JENSEN PB; TEISNER B
      QUANTIFICATION OF THE N-TERMINAL PROPEPTIDE OF HUMAN PROCOLLAGEN TYPE-I (PINP) - COMPARISON OF ELISA AND RIA WITH RESPECT TO DIFFERENT MOLECULAR-FORMS

      Clinica chimica acta
    36. SEHESTED M; WESSEL I; JENSEN LH; HOLM B; OLIVERI RS; KENWRICK S; CREIGHTON AM; NITISS JL; JENSEN PB
      CHINESE-HAMSTER OVARY CELLS RESISTANT TO THE TOPOISOMERASE-II CATALYTIC INHIBITOR ICRF-159 - A TYR49PHE MUTATION CONFERS HIGH-LEVEL RESISTANCE TO BISDIOXOPIPERAZINES

      Cancer research
    37. KREISHOLT J; SORENSEN M; JENSEN PB; NIELSEN BS; ANDERSEN CB; SEHESTED M
      IMMUNOHISTOCHEMICAL DETECTION OF DNA TOPOISOMERASE II-ALPHA, P-GLYCOPROTEIN AND MULTIDRUG-RESISTANCE PROTEIN (MRP) IN SMALL-CELL AND NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    38. SORENSEN M; SEHESTED M; CHRISTENSEN IJ; LARSEN JK; JENSEN PB
      LOW-LEVEL RESISTANCE TO CAMPTOTHECIN IN A HUMAN SMALL-CELL LUNG-CANCER CELL-LINE WITHOUT REDUCTION IN DNA TOPOISOMERASE-I OR DRUG-INDUCED CLEAVABLE COMPLEX-FORMATION

      British Journal of Cancer
    39. JENSEN PB
      THE INFLUENCE OF UNSPRAYING ON DIVERSITY OF SOIL-RELATED HYMENOPTERANPARASITOIDS IN CEREAL FIELDS

      Journal of applied entomology
    40. HANSEN JES; GRAM GJ; NIELSEN SD; SORENSEN A; JENSEN PB; SEHESTED M; NIELSEN JO; RORTH M
      TRANSDUCTION POTENTIAL OF HUMAN RETROVIRUSES IN HIGHLY PROLIFERATING SMALL-CELL LUNG-CANCER CELLS AS WELL AS NONPROLIFERATING HEMATOPOIETICSTEM-CELLS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    41. JENSEN PB; RASMUSSEN HB; PEDERSEN FB
      SERUM CONCENTRATION OF THE AMINOPROPEPTIDE OF TYPE-I PROCOLLAGEN IN PATIENTS ON HEMODIALYSIS AND PERITONEAL-DIALYSIS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    42. OTTE KE; JENSEN PB; SVENDSEN P; GRAM J; STARKLINT H; JORGENSEN KA
      HEPARIN-FREE HYPOTHERMAL HEMODIALYSIS AT 20-DEGREES-C IMPROVES BIOCOMPATIBILITY

      Blood purification
    43. MADSEN OD; JENSEN J; PETERSEN HV; PEDERSEN EE; OSTER A; ANDERSEN FG; JORGENSEN MC; JENSEN PB; LARSSON LI; SERUP P
      TRANSCRIPTION FACTORS CONTRIBUTING TO THE PANCREATIC BETA-CELL PHENOTYPE

      Hormone and Metabolic Research
    44. WESSEL I; JENSEN PB; FALCK J; MIRSKI SEL; COLE SPC; SEHESTED M
      LOSS OF AMINO-ACIDS (1490)LYS-SER-LYS(1492) IN THE COOH-TERMINAL REGION OF TOPOISOMERASE II-ALPHA IN HUMAN SMALL-CELL LUNG-CANCER CELLS SELECTED FOR RESISTANCE TO ETOPOSIDE RESULTS IN AN EXTRANUCLEAR ENZYME LOCALIZATION

      Cancer research
    45. JENSEN PB; HOLM B; SORENSEN M; CHRISTENSEN IJ; SEHESTED M
      IN-VITRO CROSS-RESISTANCE AND COLLATERAL SENSITIVITY IN 7 RESISTANT SMALL-CELL LUNG-CANCER CELL-LINES - PRECLINICAL IDENTIFICATION OF SUITABLE DRUG PARTNERS TO TAXOTERE, TAXOL, TOPOTECAN AND GEMCITABIN

      British Journal of Cancer
    46. JENSEN PB; SEHESTED M
      DNA TOPOISOMERASE-II RESCUE BY CATALYTIC INHIBITORS - A NEW STRATEGY TO IMPROVE THE ANTITUMOR SELECTIVITY OF ETOPOSIDE

      Biochemical pharmacology
    47. SORENSEN M; SEHESTED M; JENSEN PB
      PH-DEPENDENT REGULATION OF CAMPTOTHECIN-INDUCED CYTOTOXICITY AND CLEAVABLE COMPLEX-FORMATION BY THE ANTIMALARIAL AGENT CHLOROQUINE

      Biochemical pharmacology
    48. KRISTENSEN CA; JENSEN PB; POULSEN HS; HANSEN HH
      SMALL-CELL LUNG-CANCER - BIOLOGICAL AND THERAPEUTIC ASPECTS

      Critical reviews in oncology/hematology
    49. SEHESTED M; HOLM B; JENSEN PB
      DEXRAZOXANE FOR PROTECTION AGAINST CARDIOTOXIC EFFECTS OF ANTHRACYCLINES

      Journal of clinical oncology
    50. HOLM B; JENSEN PB; SEHESTED M
      ICRF-187 RESCUE IN ETOPOSIDE TREATMENT IN-VIVO - A MODEL TARGETING HIGH-DOSE TOPOISOMERASE-II POISONS TO CNS TUMORS

      Cancer chemotherapy and pharmacology
    51. JENSEN JE; JENSEN PB; NIELSEN B; KOCH C; LARSEN S; HORN T; KEMP E
      INDUCED TOLERANCE AND FLOW-CYTOMETRY ANALYSIS OF LYMPHOCYTE PHENOTYPES IN CONCORDANT XENOGRAFT TRANSPLANTATION

      Transplantation proceedings
    52. JENSEN PB; BIRKELAND SA; ROHR N; ELBIRK A; JORGENSEN KA
      DEVELOPMENT OF ANTI-OKT3 ANTIBODIES AFTER OKT3 TREATMENT

      Scandinavian journal of urology and nephrology
    53. JENSEN JE; JENSEN PB; NIELSEN B; KEMP E
      FLOW-CYTOMETRY ANALYSIS OF PAN-T-LYMPHOCYTE, CD4(-LYMPHOCYTE, CD8(+)-LYMPHOCYTE, AND PAN-B-LYMPHOCYTE IN BLOOD-SAMPLES OBTAINED FROM HEALTHY, NONTREATED RATS - COMPARISON OF LYMPHOCYTE SUBPOPULATIONS IN BLOOD-SAMPLES OBTAINED FROM RAT-HEART AND TAIL())

      Laboratory animal science
    54. HUBE F; LIETZ U; IGEL M; JENSEN PB; TORNQVIST H; JOOST HG; HAUNER H
      DIFFERENCE IN LEPTIN MESSENGER-RNA LEVELS BETWEEN OMENTAL AND SUBCUTANEOUS ABDOMINAL ADIPOSE-TISSUE FROM OBESE HUMANS

      Hormone and Metabolic Research
    55. MADSEN OD; JENSEN J; BLUME N; PETERSEN HV; LUND K; KARLSEN C; ANDERSEN FG; JENSEN PB; LARSSON LI; SERUP P
      PANCREATIC DEVELOPMENT AND MATURATION OF THE ISLET B-CELL - STUDIES OF PLURIPOTENT ISLET CULTURES

      European journal of biochemistry
    56. WABITSCH M; JENSEN PB; BLUM WF; CHRISTOFFERSEN CT; ENGLARO P; HEINZE E; RASCHER W; TELLER W; TORNQVIST H; HAUNER H
      INSULIN AND CORTISOL PROMOTE LEPTIN PRODUCTION IN CULTURED HUMAN FAT-CELLS

      Diabetes
    57. SEHESTED M; JENSEN PB
      MAPPING OF DNA TOPOISOMERASE-II POISONS (ETOPOSIDE, CLEROCIDIN) AND CATALYTIC INHIBITORS (ACLARUBICIN, ICRF-187) TO 4 DISTINCT STEPS IN THETOPOISOMERASE-II CATALYTIC CYCLE

      Biochemical pharmacology
    58. SVENSSON C; JENSEN PB; MICHELSEN B; BILLESTRUP N; NIELSEN JH
      THE EXPRESSION OF A NOVEL GROWTH-HORMONE REGULATED GENE, PREF-1, IN RAT ISLETS OF LANGERHANS

      Diabetes
    59. BROCK I; HIPFNER DR; NIELSEN BS; JENSEN PB; DEELEY RG; COLE SPC; SEHESTED M
      SEQUENTIAL COEXPRESSION OF THE MULTIDRUG-RESISTANCE GENES MRP AND MDR1 AND THEIR PRODUCTS IN VP-16 (ETOPOSIDE)-SELECTED H69 SMALL-CELL LUNG-CANCER CELLS

      Cancer research
    60. SORENSEN M; SEHESTED M; JENSEN PB
      CHARACTERIZATION OF A HUMAN SMALL-CELL LUNG-CANCER CELL-LINE RESISTANT TO THE DNA TOPOISOMERASE I-DIRECTED DRUG TOPOTECAN

      British Journal of Cancer
    61. JENSEN PB
      DIFFERENTIAL SENSITIVITY PATTERNS IN SMALL-CELL LUNG-CANCER CELL-LINES - DETECTION AND CIRCUMVENTION OF RESISTANCE TO TOPOISOMERASE-II TARGETING DRUGS

      Danish medical bulletin
    62. HOLM B; JENSEN PB; SEHESTED M; HANSEN HH
      IN-VIVO INHIBITION OF ETOPOSIDE-MEDIATED APOPTOSIS, TOXICITY, AND ANTITUMOR EFFECT BY THE TOPOISOMERASE II-UNCOUPLING ANTHRACYCLINE ACLARUBICIN

      Cancer chemotherapy and pharmacology
    63. PETERSEN LN; JENSEN PB; SORENSEN BS; ENGELHOLM SA; SPANGTHOMSEN M
      POSTINCUBATION WITH ACLARUBICIN REVERSES TOPOISOMERASE-II MEDIATED DNA CLEAVAGE, STRAND BREAKS, AND CYTOTOXICITY INDUCED BY VP-16

      Investigational new drugs
    64. JENSEN PB; SORENSEN BS; SEHESTED M; GRUE P; DEMANT EJF; HANSEN HH
      TARGETING THE CYTOTOXICITY OF TOPOISOMERASE II-DIRECTED EPIPODOPHYLLOTOXINS TO TUMOR-CELLS IN ACIDIC ENVIRONMENTS

      Cancer research
    65. SORENSEN BS; JENSEN PB; SEHESTED M; JENSEN PS; KJELDSEN E; NIELSEN OF; ALSNER J
      ANTAGONISTIC EFFECT OF ACLARUBICIN ON CAMPTOTHECIN INDUCED CYTOTOXICITY - ROLE OF TOPOISOMERASE-I

      Biochemical pharmacology
    66. SEHESTED M; JENSEN PB; SORENSEN BS; HOLM B; FRICHE E; DEMANT EJF
      ANTAGONISTIC EFFECT OF THE CARDIOPROTECTOR (-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF-187) ON DNA BREAKS AND CYTOTOXICITY INDUCED BYTHE TOPOISOMERASE-II DIRECTED DRUGS DAUNORUBICIN AND ETOPOSIDE (VP-16)())

      Biochemical pharmacology
    67. JENSEN PB; SORENSEN BS; SEHESTED M; DEMANT EJF; KJELDSEN E; FRICHE E; HANSEN HH
      DIFFERENT MODES OF ANTHRACYCLINE INTERACTION WITH TOPOISOMERASE-II-SEPARATE STRUCTURES CRITICAL FOR DNA-CLEAVAGE, AND FOR OVERCOMING TOPOISOMERASE-II-RELATED DRUG-RESISTANCE

      Biochemical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 19:13:45